5.53
0.00%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About CompuMed
Its shares trade under the ticker CMPD. It has been listed since 28 May 1987. In the fiscal year to 30 September 2025, it reported revenue of $7.5m and a net loss of $64,227. At that date it held total assets of $5.0m and shareholders' equity of $3.1m.
CompuMed, Inc. engages in the provision of enterprise telemedicine solutions. The company is headquartered in Los Angeles, California. The firm's telecardiology and teleradiology offerings provide direct access to the United States Board-Certified specialists through cloud-based technology and integrated medical devices. Its solutions primarily support the diagnosis and treatment of various diseases, particularly cardiovascular disease and osteoporosis. The firm operates a network for remote electronic processing of electrocardiograms (ECGs), echocardiograms (Echos), ultrasound studies and X-rays. The firm provides ECG equipment and cardiology services to its clients. Its ECG devices include GE MAC 1200, Mortara ELI 100 and Schiller AT-102. Its ultrasound devices include GE Vscan, GE Vivid e and GE Vivid i. The company has created an electronic telemedicine infrastructure to link clinical diagnostic equipment data collected at the patient's point of care with specialists through its call center. The company also provides access to specialists for consultations.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Technology
- Listed since
- 28 May 1987
- Employees
- 8
- Website
- compumedinc.com ↗
Leadership
Pay as last reported
- Mr. Lee KeddiePresident, Chief Executive Officer, Director, since 2014
- Ms. Phuong DangPrincipal Financial Officer, Controller, Secretary$128,000
- Mr. Charles GillmanDirector
- Mr. Loren Den HerderDirector
- Mr. Mark CrockettIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- CompuMed's telecardiology and teleradiology solutions provide direct access to US Board-Certified specialists via cloud technology.
- The company operates a network for remote processing of ECGs, Echos, ultrasounds, and X-rays through integrated medical devices.
- CompuMed offers ECG equipment like GE MAC 1200 and ultrasound devices including GE Vscan and GE Vivid e.
Weaknesses
- CompuMed has only 8 full-time employees, limiting operational capacity and scalability.
- The company's focus on cardiovascular disease and osteoporosis may restrict market diversification.
- CompuMed's reliance on specific medical devices like GE MAC 1200 could pose supply chain risks.
Opportunities
- Expanding telemedicine infrastructure could increase access to specialists in rural US regions.
- Growing demand for remote diagnostics in the Health Care sector presents new market potential.
- Partnerships with healthcare providers could enhance CompuMed's telecardiology services reach.
Threats
- Competition from larger telemedicine firms in the Health Care industry may impact market share.
- Regulatory changes in the US healthcare sector could affect telemedicine service delivery.
- Economic downturns might reduce healthcare spending on telemedicine solutions.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.